Autolus Therapeutics Plc (AUTL)
1.39
-0.02
(-1.42%)
USD |
NASDAQ |
Apr 06, 16:00
1.395
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics SG&A Expense (TTM) : 131.95M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Mereo BioPharma Group Plc | 23.06M |
| Biodexa Pharmaceuticals Plc | 6.375M |
| NuCana Plc | 10.74M |
| Bicycle Therapeutics Plc | 79.52M |
| DBV Technologies SA | 36.08M |